Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 ] 105
batch____ bits E-value N 100.0% 1:105 MSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSMALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
1 UniRef50_A5FX71 Small multidrug resistance ... 127 1e-28 1 30.1% 2:104 184:286 -SYFLLAIAIACEVAGTSFLKASDGFTLPVQTIGTLMFYAAAFYLLAIIVRTMPIGVVYAIWSGAGIVLISAVGWLRFGQSLSPATMFGIAVIAAGVVIVNLSS-
2 UniRef50_A1BHK2 Small multidrug resistance ... 105 3e-22 1 35.2% 1:105 16:120 MPWLYLVLAIIFEVSGTTCMKLSEGFTRIVPTLFIFIFYAVSFTFVTLTVKVLPLGLTYAVWSAIGTASITIVGIFWFGEGINIVKTISLLFIIIGVVGLHFSQE
3 UniRef50_A6CJP9 Chaperone n=1 Tax=Bacillus ... 105 4e-22 1 46.7% 1:105 16:120 MAWIYLVIGGVLEIGWAIGISFSDGFTDLTPSIITILLLLISFYFFAKSMKMIPIGTAYAVFTGIGAGGTSIIGMVFLGEEISLIKIGFISLLIFGVLGLKFSSN
4 UniRef50_Q1IH96 Small multidrug resistance ... 105 6e-22 1 40.0% 1:105 1:105 MCWLWLFLAIALEVAATILMKYSDGFTRFGPTVGMLVLYALSLAPLARVLKELEVGAVYAIWSALGTVAVALLGMVLFHEPANALKVFSIVLIIVGVVGLNLSGR
5 UniRef50_Q2W7T1 Membrane transporters of ca... 105 6e-22 1 57.3% 1:103 38:140 MPWIYLLSAGLLEIGWAVGLKYVDGLSRPLPLVLTGAAMVGSVVLLGMAVRTLPLGTAYAVWTGIGTVGTVIAGMILFAEPADALRLFCMAMIVAGILGLKLA--
6 UniRef50_Q6MM86 Putative multidrug efflux t... 104 9e-22 1 32.4% 1:105 1:105 MAYVYLAAAIIFEVFGTITMKYSEGFTKVLPSVLTVACHGICFISLTVALKYLPVSNVYAIWAGVGTALMAFLGLVIFNEPLPLQKVVATTLIIAGVVILNLGES
7 UniRef50_A6SU21 SugE-like protein n=11 Tax=... 101 5e-21 1 62.5% 1:104 41:144 MSWTILIIAGLFEIGWAIGLKYTEGFTRLWPTVGTVVAMVISVALLGVAMKTLPVGTAYAVWTGIGTVGTVILGMVLLGDAVTVVRILCIMLIVSGIAGLKYFS-
8 UniRef50_Q8GAI6 Putative transporter n=1 Ta... 98 1e-19 1 30.1% 2:104 53:155 -AWLYLGSAITTEVTGTVILDFSEGFQLPAQTTAAMALYAFSFFLLTRALRAVPLSVAYATWSGLGTVAVAFAGAIIHGEAVTLGRITAITAVIGGIVILNLAT-
9 UniRef50_B7HXW0 Multidrug resistance protei... 98 1e-19 1 33.7% 1:104 1:104 MQWIYLCLAILFEVAGTTAMKLSDGLTKLVPSILIFVFYVVSFAFLSFALKGMEMSVAYAVWSGMGIVTITTIGFIYFGESINIIKILAILFILIGVVILNFNS-
10 UniRef50_B1HW14 Multidrug resistance protei... 98 1e-19 1 31.7% 2:105 3:106 -GYLFLTLSIISEVFATTMLKLSDGFTVLGPSVAVALGYGISFYSLSLCLKTLPLSLAYAIWSGVGTALTVIVGIVIWDDMFNLYSALGIALIIGGVILLNEGNR
11 UniRef50_P23895 Multidrug transporter emrE ... 97 2e-19 1 32.0% 3:105 4:106 --YIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLIINLLSR
12 UniRef50_Q2KWD3 Quaternary ammonium compoun... 96 3e-19 1 37.1% 1:105 1:105 MKWLYLALAIGFEIIATSALKASDGFSRLLPSIITVAGYMVSFYCLSLTLRELPVGIAYAVWSGVGIVAISLIGVFFFQQTLDLAAMVGIALIVAGVIVMNVFSK
13 UniRef50_O32227 Uncharacterized membrane pr... 96 4e-19 1 35.2% 1:105 1:105 MNWVFLCLAILFEVAGTVSMKLSSGFTKLIPSLLLIFFYGGSLFFLTLTLKSIDVSVAYAVWSGMGIVLITVVGFLFFQEHVSVMKVISIGLIIAGVVSLNLIEH
14 UniRef50_Q13BV5 Small multidrug resistance ... 95 7e-19 1 28.2% 2:104 15:117 -SYAALGCAIVLETIGTALLAQSQQFTKPWPSVGTAVCYVLSFYLLSHALKTMPVGIAYAIWSGLGIVLISAVGYIAFRQTLDLAAIIGIGFILTGVVIVNAFS-
15 UniRef50_Q3ARL8 SMR drug efflux transporter... 94 1e-18 1 37.1% 1:105 1:105 MHWLYLTLAIFLEVAGTTSMKLSEGFSKWLPTLFVFVFYGLSFTFVAQALKILPVSITYAIWSAVGTAAIAIIGIVWFGEQMSALKLGSLLLIIIGVMGLHFSQE
16 UniRef50_B3QZ17 Small multidrug resistance ... 94 2e-18 1 44.8% 1:105 17:121 MSWIYLILAILLEVSGTTSMKLSDGFSKFWPSAMIFVFYALSFTSLTYALKELEVSVTYAVWSGLGTVLIALIGIVWFKESVNPMKIISIAVIIIGVIGLNLSHR
17 UniRef50_D2S0K9 Small multidrug resistance ... 94 2e-18 1 53.8% 1:104 5:108 MSWYLLILAGLFEVSWAIGLEYSDGFTKPIPTLGTAVALILSMVLLAQAIKDLPIGTAYAVWTGIGAVGTASLGIILFDEPATLARIGFISLILVGIVGLHFVS-
18 UniRef50_C0R5F5 SugE protein n=4 Tax=Wolbac... 94 2e-18 1 44.2% 1:104 1:104 MNWIYLLLSSLIEVFWVITLKHSCGFTHLVPSIISIFSMALSTYLLSLATRSIPIGVCYAIWTGVGAIGASILGVYLFDEPVNLFEVICFILVTFGIIGLKLFD-
19 UniRef50_C4K308 SMR-type multi-drug efflux ... 92 5e-18 1 40.0% 1:105 1:105 MYWLLLILAGLFEIAFAITLKYSDGLTKLKPTLLFIFFGALSFMCLSKTLNKIPIGTAYAVWTGIGATGTTILDIFIFNEPISILRLFFITTLVISIIGLKISSK
20 UniRef50_UPI0001B55FB7 small multidrug resistance ... 92 5e-18 1 43.7% 2:104 22:124 -AWGILLFAGVCEIAFAVSTDGSRGFTNLPWSIATVITAAATIFTLSLALRTIDVGVGYAVWTGIGASGAAIFGAIIFGESLGPLRILFLAVIIAGVICLKLAG-
21 UniRef50_C6QTF0 Small multidrug resistance ... 92 5e-18 1 30.8% 2:105 3:106 -GYIALGISIISEVFGTTMLKLSEGFTNIFPSIGVIVGYGLSFYFLSLCLKTVPLSLAYALWSGIGTALTTLIGVLLWRDPFNIITLVGLILIIGGVALLNASKS
22 UniRef50_B2SL07 SugE n=9 Tax=Xanthomonas Re... 92 6e-18 1 52.9% 1:104 1:104 MLWIYLLLAGLFEIGFAMGLKYSDGFTRLWPTVLTIGLAGTSLWFLTQALKTIPVGTGYAIWTGIGALGVTIAGIALFGDSASWPRLACIGLIVSGVIGLKFVS-
23 UniRef50_B0T330 Small multidrug resistance ... 92 7e-18 1 63.5% 1:104 1:104 MAWLILFIAGLFEIGWAVGLKFTEGFTRPIPTVFTGVSLVASMGLLGWAVKSLPLGTAYAVWTGVGAVGTAIVGILLFKEPATVGRLVCLALIVSGILGLKLFT-
24 UniRef50_Q1C804 Spermidine export protein m... 92 7e-18 1 29.1% 3:105 4:106 --WIFLGLAIIAEIIGTLSMKYASVSGEMTGHIVMYFMITGSYVMLSLAVKKVALGVAYALWEGIGILIITIFSVMWFGETLSPLKIAGLVTLIGGILLVKSGTR
25 UniRef50_B6JGL2 Multidrug transporter EmrE ... 92 8e-18 1 31.4% 1:105 1:105 MTYLYLVAAIVFEVIGTAALQASEQFTRPKPLVLTAFGYIASFYFLSLVLRAMPVGIAYAIWSGLGVVLITLVGFVWFGQRLDMAAVIGLSLIIAGVAIINLFSR
26 UniRef50_A9B1S7 Small multidrug resistance ... 92 8e-18 1 60.8% 1:102 1:102 MAWFYLIVAGVLEVGWAVGLKYSEGLTKLGPSLATGVMLAASMALLGMALRDLPLGTAYAIWTGIGTAGTAILGIWLFGESAQPLRLACLVMIVAGIIGLKL---
27 UniRef50_B8FJS7 Small multidrug resistance ... 91 8e-18 1 36.9% 3:105 4:106 --WIFLAIAIVSEVIATSALKSSEGFSRLWPSVIVTVGYMSAFYFLSLTLKTIPIGVAYAVWAGSGVALIALIAWIFFGQALDLPAILGLSLIVAGVVVLNLFSK
28 UniRef50_A7NFS5 Small multidrug resistance ... 91 1e-17 1 27.7% 4:104 7:107 ---MLLFGAIVCELIGTNALKAADGFTRLMPTLLVIAGYGASFYLMSLSLRTIPLGVAYAIWSGLGTAAIAVIGVLVWREQLNITGVIGIVLIIAGVVLLNMFG-
29 UniRef50_A5GJB5 Small Multidrug Resistance ... 90 1e-17 1 34.3% 3:104 7:108 --WALLLLAIGAEVIGTSCLKVSDGFSRPWPTLAVLTAYGLSMTLMSRVVKTIPMGISYALWSGIGIVAIVLIGVVAYRQVPTGGQLIGMGLITAGVLIVNLSS-
30 UniRef50_B4SG70 Small multidrug resistance ... 90 2e-17 1 38.1% 1:105 1:105 MHWIYLIMAILFEVSGTTCMKISDGFSKLAPTLFIFIFYGLSFTFLSLALKVLPIALTYAIWSGIGTAAITVIGVIWFGEGINAIKLASLLLIIIGVAGLHFSQE
31 UniRef50_Q2LW97 Quaternary ammonium compoun... 90 2e-17 1 66.7% 1:105 13:117 MDWIIIVLAGLFETGWAIGLKYTDGFTRLWPTVGTVFSMVISLALLGIAMKSIPVGTAYAVWVGIGAVGTAMLGIVLLGEPVNSGRILSLALIIAGIVGLKLTTQ
32 UniRef50_C5AGU8 Quaternary ammonium compoun... 90 2e-17 1 33.7% 2:105 5:108 -AYAWLAIAIVAEVIGTSALRASEGFTRLMPTLIVVVGYGIAFYGLSLTLKSLPVGIVYAIWSGAGIVLITLVAIVLYRQVPDWPAVIGLGLIIAGVAVLNLFSK
33 UniRef50_B7GJU1 Membrane transporter of cat... 90 3e-17 1 26.7% 1:101 5:105 MYWLYLFVAIIFEVIGTTAMKWSNGLTNIRGTIVMFVCYGLSFTSLAVALKGIDISIAYAIWSGLGIVCITFIGLFLFHEMMSVKKIVGIAFVIVGVVLLK----
34 UniRef50_D0WHL3 Quaternary ammonium compoun... 89 3e-17 1 28.8% 2:105 14:117 -SWLLLAAAIGLELCGTTCIKLSEGFTQPIFVLGVIVAYSICFTAFSVALRDLPLGLAYGVWGGIGTIGTAVIGFFAFGEPMTAIMALGIVLIIAGVAFMNAGTD
35 UniRef50_C6DEC5 Small multidrug resistance ... 89 4e-17 1 26.0% 2:105 7:113 -SWLWMLLVILSETSATSTLKmsQGITKVALLAVIILLYCVCYYSLSKAVKHLPVGLAYATWSGTGILLVSTLSIIFYGQRPDIPAIIGMSVIAAGIAIMNLFSK
36 UniRef50_A4WRX1 Small multidrug resistance ... 89 4e-17 1 35.9% 3:105 7:109 --YAFLVFAIFAEVVATTALARSDGFTRLWPSVITVLGYSIAFACLSVTLKVMPTGVVYALWSGLGIVFIAAIGWLVYDERLDLPALIGLGLILAGVLVVNLFSK
37 UniRef50_O06999 Uncharacterized membrane pr... 89 4e-17 1 39.0% 1:105 1:105 MAWFLLVIAGIEEIIAAIAMKYIDGTRKKWPIIVMTVGFGLSFYCLSQAMIVLPAGVAYAVWTGIGSIGVSAVGLIWFKERFQLSQVISLCLILAGVIGLRLTSS
38 UniRef50_C6B3X2 Small multidrug resistance ... 89 5e-17 1 51.9% 1:104 25:128 MAWALLGIAGILEIGFAFFMKSSLGFTRLIPTLLTVVTGLSSVFLLSMSLRTLPVGTGYAVWTGIGAAGTAILGMVALGDAASPMRLFCIALILAGVIGLRLVS-
39 UniRef50_A4VR41 Multidrug efflux SMR transp... 89 5e-17 1 29.8% 2:105 12:115 -GYVYLAFAICAEVVATTSMKALAGFNRPLPLLLVVTGYSLSFWMLALVVRTIPVGIAYAIWAGLGIVLVSVAAAVLYRQYLDLPAVLGMGLIIAGVVVIQLFSR
40 UniRef50_C7RU41 Small multidrug resistance ... 89 5e-17 1 32.4% 1:105 44:148 LYWLLLVIAIVAEVIATTMLKSTEGFTRLWSSVIVITCYEIAFILLALCVKRIAVSVVYALWSGVGVALVTLVAWFWLDQPLDAAGLAGVGLIIAGVVAINGFSK
41 UniRef50_Q55339 Quaternary ammonium compoun... 89 5e-17 1 30.8% 1:104 1:104 MPYIYLIISISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYATWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGVVSLNIFG-
42 UniRef50_Q65JB2 Multidrug resistance protei... 89 6e-17 1 33.7% 4:101 5:102 ---IFLAAAILSEVFGSTMLKLSEGFSAPLPAAGVIIGFAASFTFLSFSLKTLPLSAAYATWAGTGTALTAAIGHFIFQEPFNLKTLIGLTLIIGGVFLLN----
43 UniRef50_Q0T949 Quaternary ammonium compoun... 88 7e-17 1 31.7% 2:105 5:108 -GFLWLALSIGSEITGTSMIKKTNGFRRLWPSVLVVCAYSTCYFALTRAMSTIPVGVAYSLWCGFGIVGVTIFSMILYKQKPDLPAIFSMLLIISGGIIMNVFSN
44 UniRef50_B1XY85 Small multidrug resistance ... 88 8e-17 1 37.5% 2:105 10:113 -AWSVLAVAIVFEVAGTTCLRLSEGLSRLWPSLLIFAFYGVSFSLNAMVVRTLGVGVVYAVWSGVGTVLTALIGYLWFKEPATALKLVSAGLIVMGVFGLHASSR
45 UniRef50_A5V865 Small multidrug resistance ... 88 9e-17 1 41.9% 1:105 5:109 MAWIWLIVGGCFEVGFTTCLRFVDGFRNIPWTLGFLASVTLSMGLLEVASRSIPMGTAYAVWGGIGAIGTVIVGMAWFGEPATPLRIVLIFAIVACIAGLKLTAH
46 UniRef50_Q8GAI5 Putative multidrug resistan... 88 9e-17 1 35.0% 3:102 13:112 --WPLLLLAIAAEVAATSLLPQTNGFRKLKPTVAVACLYTVAFALLAQILKFTDIGIAYALWAGLGTASVAVIGVLFRNERFSWKHAIGLALVVTGVVTLNL---
47 UniRef50_A0KHW4 Quaternary ammonium compoun... 88 9e-17 1 24.3% 3:105 8:113 --WLWMLLVIVSETSATSTLKmsEGTTKMLLLGLLVLLYCTCYYSLSRAVKDIPVGLAYATWSGTGILVVSTLGMAFYGQHPDTAAMIGMAVIASGIVIMNLFSK
48 UniRef50_Q79IF2 Quaternary ammonium compoun... 88 1e-16 1 82.9% 1:105 1:105 MSWIVLLIAGLLEVVWAIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIIGLKLSTH
49 UniRef50_A1V9H1 Small multidrug resistance ... 87 1e-16 1 30.4% 3:104 17:118 --WLCLLASIVFEVAGTSVMKLSQETWPLLGMGCMYLLLGLSYFFLARAVMKLPVGVAYAFWEGLGLTLITIVSVTLLDERLDAMRLAALGMVLAGTLLVHHGT-
50 UniRef50_D1R837 Putative uncharacterized pr... 87 1e-16 1 29.4% 3:104 4:105 --YLYLFLAIITEIIATSALKVSDGFTKPLASIIVLVGYFFAFWLLSLTLKVLPVSIVYAIWSGLGILGISCIGIWYFKEMFGVWHFIGTALILAGVVILSIVT-
51 UniRef50_P0AGC9 Quaternary ammonium compoun... 87 1e-16 1 34.6% 2:105 3:106 -GWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSK
52 UniRef50_A7GSM9 Small multidrug resistance ... 87 1e-16 1 42.3% 1:104 1:104 MAWVFLILAGICEVTGVLFMKIATKKKGWFPKLILIANFGISFFFLSLAMNVLPMGTAYAIWTGIGTAGSALLGILIFHESADWRRLVFLSCIVCGAIGLKLLS-
53 UniRef50_Q8XGT8 Quaternary ammonium compoun... 87 1e-16 1 85.7% 1:105 1:105 MSWIILLIAGLLEVVWAVGLKYTHGFSRLTPSIITITAMVISMALLSWAMKTLPVGTAYAIWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIIGLKLSAH
54 UniRef50_A1VCN1 Small multidrug resistance ... 87 2e-16 1 34.6% 2:105 4:107 -SWIILFLSIFCEVTGTSCLKLSDGFSKIIPTISVFLFYGLALWGLSVVVKKMDVSIAYAVWSGVGTATVAMIGICIFGERATVVKICSLLLIIIGVVGLNYTSS
55 UniRef50_UPI0001C428B7 multidrug resistance protei... 87 2e-16 1 41.7% 3:105 13:112 --WGKVVIAAFFEVGWVIGLKHA---SLWWEWMITIIAIAVSFYLLIQAGKRLPVGTAYAVFVGLGTAGTVSAEFLLFGEPLEIIKVLLIGLLLAGVIGLKLVTS
56 UniRef50_Q04QB1 Cation efflux protein n=6 T... 87 2e-16 1 38.2% 1:102 1:102 MAWIYLIIASTFEIGFTTCLKLSDNFTKPTWVGGFVVSAVFSLAFLNKAVQTIPMGTAYAIWTGLGAAGTILVGIVIHGEPIDFWRGFFLSTLILSVLGLKF---
57 UniRef50_O87866 Quaternary ammonium compoun... 87 2e-16 1 28.6% 1:105 1:105 MHYLYLFISIATEIIGTSFLKTSEGFTKLWPTLGTLLSFGICFYFLSLTIKFLPLNITYATWAGLGLVLTTIISVIVFKENVNLISIISIGLIVIGVVLLNVFGE
58 UniRef50_Q8CNC0 SMR-type multidrug efflux t... 86 3e-16 1 35.2% 1:105 27:128 MQWLKVILAGFIEIIWVTGLDQAHS---LFTWIFTLFFIALSFFLVIDASKHLPVGTVYAFFVGIGAVGTVLVDMIFFNQPFTFTKIFLIMTLILGIIGLKLTTD
59 UniRef50_Q65KV0 Multidrug resistance protei... 86 3e-16 1 41.3% 1:104 1:104 MEWICLIAAGILEMLGVTMMNQFHKDKRVRWIFLLIIGFAASFFLLSLAMETLPMGTAYAVWTGIGTVGGALVGILFYGEPKDGKRIFFIALILGSAVGLKLIS-
60 UniRef50_A0KHW3 Quaternary ammonium compoun... 86 3e-16 1 30.8% 2:105 5:108 -GFLWLALSIGSEITGTSMIKKTNGFSRLGPSILVVCAYSLCYFALTRAMSTIPVGVAYSLWCGFGIVGVTICSMILYKQKPDLPAILAMALIISGGVIMNVFSS
61 UniRef50_C7R3X4 Small multidrug resistance ... 86 4e-16 1 39.0% 2:101 23:122 -AWAVLLLSAALEATWATALGASQGFTHLGPTLLFALTAPASMIGLSLGMLRIPVGTAYAVWTGLGAVLTVGYAVTTGTELLTTAKILALALIVGCTIGLK----
62 UniRef50_D2PSB8 Small multidrug resistance ... 86 4e-16 1 37.5% 2:105 21:124 -AWLVLLLAGAFEVGYALSVEGSEGFTVLSWSLVAVVFFLLTLFALSVALRTIDVGIGYAVWAGIGAVGAALLGPVFFAETLTPVKALWLTVIIAGVVWLKLSDR
63 UniRef50_A0AGY2 Complete genome n=16 Tax=Ba... 86 4e-16 1 50.0% 1:104 1:104 MAWFYLIMAGLSEIVWAFGLKESHGFTILGWSLLTIAFLIVSFGLFSMSMKAIPIGTAYAVFTGIGAAGTAIIGMIFLSEGISFWKIVSLLVLLSGIIGLKLVD-
64 UniRef50_B4T6P3 Multidrug transporter EmrE ... 85 4e-16 1 31.4% 4:105 7:108 ---IFLFIAIVVEVIATISLKLSDSFTRLVPSLVTIIGYCIAFWCLTIPMRTIPAGIIYAIWSGVGIVLIGLIGWLFLGQKLDMPAIIGMLLIICGVIVINLFSK
65 UniRef50_UPI000197A738 efflux protein n=1 Tax=Heli... 85 5e-16 1 24.3% 2:104 6:109 -AYILLTFAILTEVLATSFMKAGdsGNRIFGFIAMYALLVLSYYFMALSLKRLSISVAYALWEVLGVLCVVCIGIFYFGESLKWQEYLGICLSLCGIALINIAE-
66 UniRef50_A0SKJ2 Smr-2 n=5 Tax=Gammaproteoba... 85 5e-16 1 46.6% 1:103 1:104 MAWIYLILAGLFEIGWPVGLKMAQveTRWSGVGIAVAFMAVSGFLLWLAQRHIPIGTAYAVWTGIGAAGTFLVGVLYYGDPTSVARYFGVALIVAGVITLKLA--
67 UniRef50_Q721W3 SugE protein n=15 Tax=Bacil... 85 6e-16 1 41.3% 1:104 1:104 MDWIFLLVAGLCEMVFVVMLKLSDGFKKVGYAILTIIFMSASFFLLSLALKTIPIGTGYAIWTGIGAVGSVTLGMIVFKERKSVGKLLFITMIIAGVVGLKLTS-
68 UniRef50_Q0BTF4 Quaternary ammonium compoun... 85 6e-16 1 38.6% 5:105 6:106 ----WLLLAILSEVIGTVGLKQSEGFSKPGWIAVIALAYGAAFFMLAQALRTMPVGTAYAVWSGIGTAAIALIGVVFLGQKLDAAALAGIGLIIAGVLTINLLSS
69 UniRef50_O87868 Quaternary ammonium compoun... 85 6e-16 1 28.6% 1:105 1:105 MPYLYLLLSIVSEVIGSAFLKSSDGFSKLYPTITTIISFLICFYFLSKTMQHLPLNITYASWAGLGLVLTTIVSVLIFKEQINLISIISIILIIFGVVLLNTFGS
70 UniRef50_Q7MZY0 Quaternary ammonium compoun... 85 7e-16 1 72.1% 1:104 1:104 MSWFVLVIAGLFEVVWAVGLKYTHGFTRLIPSLITASAVALSMGLLAYAMKGLPIGTAYAVWTGIGAVGTAIFGIIVFGESASFARILSFALIIAGIIGLKLSS-
71 UniRef50_Q12TP7 Multidrug resistance protei... 85 7e-16 1 27.6% 1:105 1:105 MSYSLLAISIFFEICGTVCMKISDGYSNISASLMIFVFYGISFSIFPFALKNIDVSLAYAIWSGVGTASMTLIGVYYFKEPATTIKMVSIFIVMAGVLGLNLSDK
72 UniRef50_P20928 Quaternary ammonium compoun... 85 7e-16 1 75.0% 1:104 1:104 MSWIILFVAGLLEIVWAVGLKYTHGFTRLTPSIITISAMIVSMGMLSYAMKGLPAGTAYAIWTGIGAVGTAIFGIIVFGESANIYRLLSLAMIVFGIIGLKLAS-
73 UniRef50_D2P2Z6 Small multidrug resistance ... 84 1e-15 1 38.5% 1:104 1:104 MEWIFLAVAIVLELVGTTLMKMSDGLTKLLPSAGMFIAFILCFGSLALALKKIPVSAAYAIWSGVGIVAIAVIGVLFFKENVNAIKVVSILLIVAGVVGLNLGG-
74 UniRef50_Q4KJ25 SugE protein n=8 Tax=Pseudo... 84 1e-15 1 45.5% 1:101 1:101 MAWMFLLLAAAFEVTFAMGMKYAEGFTRPWPSLLTVVAAVGGIYFLTLAMRELPVSVAYPIWTAIGSLGTVLLGCLLLGESLTAVKLVSVGLIVAGVAGLK----
75 UniRef50_B4S2Z6 Putative exporter protein (... 84 1e-15 1 46.6% 1:103 1:104 MSWIYLITAGLLEIGWPVGLKMseAETRVMGILLAIGFMAASGFCLWMAQKQIPIGTAYAVWTGIGAAGTFLVGVVFYGDPASLARYFGVALIVAGVVVLKLA--
76 UniRef50_A9CI07 Quaternary ammonium compoun... 84 1e-15 1 26.7% 1:105 6:110 LTYGALVAAIVCEVIATSFLQQSQQFTRLLPTVLMALFYGAAFYLLSFTLRALPVGVAYAIWSGLGIVLISGIGYFVFRQTLDLAAVIGLGFIITGVVIVNVFSK
77 UniRef50_Q2NVC0 Spermidine export protein m... 84 1e-15 1 32.0% 3:105 4:106 --WIFLALAITAEVIGTLSMKYATVNGQITGHIVMYIMITASYILLSLAIKRVALGVAYALWEGIGILFITLFSVMWFDEPFSLTKLAGLAILVIGIVMLKSGTR
78 UniRef50_A9BRH0 Small multidrug resistance ... 84 1e-15 1 57.1% 1:105 1:105 MAWVYLLVAGLLEVVWAFSMKQSHGFTRLVPSAITIVTMIASFGLLAVAMRSLPLGTAYTIWTGIGAVGAFLVGITVLGEQVSAMRIGAAVLIVSGLVLMKLSSD
79 UniRef50_Q28MS4 Small multidrug resistance ... 84 1e-15 1 34.6% 1:104 1:104 MAWLYLVFAILAEVIATSALKASEGFTQGPAAAMTVVGYAVSFYFLGLAFRTIPLGVAYAVWAGVGIVTVTLIGVYWFNQPIGAGQAAGIAMILGGVLILRLMT-
80 UniRef50_Q0KAH1 Quaternary ammonium compoun... 84 1e-15 1 53.9% 1:102 14:115 MAWMLLVLAGLIEIVMALALKHTDGWTRPGPTALGIGAALASIFLLSAALRHLPVGTAYAIWTGIGAIGVTVVGILFLGESAAPMRLVLIGLIFVGIGGLKL---
81 UniRef50_D2EKF2 Predicted protein n=1 Tax=P... 84 1e-15 1 28.6% 1:105 1:105 MHYIVLIFAILCELVGTNLMKLSAGFTKISFSAGTLGAYALCFYFLSLSLRGITLNVAYATWGGAGIVLATLLSYLVYHEETSGTQLFGIVLIVIGVILANLAGN
82 UniRef50_A4FQJ2 Small multidrug resistance ... 84 2e-15 1 49.0% 1:104 1:104 MAWVVLMLSGMLEAGWAIALKMSDGFSRLWPTVWFAVLATGSFAGLAWAMRTLPVGPAYAVWVGIGAALTAVIGMVWLGDPVSVLKVVSIVLIAAGVIGLNLSG-
83 UniRef50_UPI0001693391 EbrB n=1 Tax=Paenibacillus ... 84 2e-15 1 29.1% 2:104 3:105 -GYLTLAVSLTLEMFGATMLKLSKGFTKWLPAVLVVFGYGSAFYFFSKSLTYLPLNLAYATWAGLGTSLTVLVDYFFFKESLTKRSLLGLVLIVCGVFILNLSG-
84 UniRef50_D2AX85 Small multidrug resistance ... 83 2e-15 1 42.9% 1:105 1:105 MAWIYLLIAAVFEVVFALATNATEGFTQLGPSLLTAAAAAVGIFFLSLALKTLDVGVGYTIWTGIGSVGTVVLGAVIFGEEFTIWKVLAFVLIIGGVLGLKLSDR
85 UniRef50_B0V7S2 Suppressor of gro n=20 Tax=... 83 2e-15 1 51.9% 1:104 1:104 MAWAILILAGVFEVIWAYSMKMSEGFTRLTPSIITVVFMILSVVLLSISMKTLPLGTAYTVWTGIGAIGSFLVGIFFLHEPIGAMRMIAAVLIVSGLVLMKISS-
86 UniRef50_A3Z6D8 Putative mebrane transport ... 83 3e-15 1 31.0% 6:105 21:120 -----LFLAIAAEQIGTSAMKASNGFTQLPLTVLALAGYALSMLWFGRSMRVLPMGFAYALWVGVGMVVASVSGVFLFSEALTPSVFLGLMFVFVGILVLNSSQQ
87 UniRef50_Q15YS1 Small multidrug resistance ... 83 3e-15 1 26.9% 2:105 6:109 -GYWYLGAAIMAEVIGTLALKASEGFNNTISSAVCVIGYATAFYFLSLVLKTVPVGIAYAIWAGMGIVLIALFSAIFYKELPDLAAIAGMSLILSGVVIINVFSK
88 UniRef50_Q4HSK8 SugE protein n=2 Tax=Campyl... 83 3e-15 1 27.6% 1:105 9:110 LAWCLVLLGGFVECFWVSGLKYAN---ELIWYVLTGCGILISFCCAVVAMQKIEVSVAYAVFVGIGTAGVVLAEMLFFNEPFSLLKISLIFILLLGVVGLKFVSR
89 UniRef50_D0M338 Quaternary ammonium compoun... 83 3e-15 1 27.5% 4:105 12:113 ---LALSIAIVCEVIATSYIPKTEQFTKMMPSTVVLIGYGIAFFLLSVTVKTMPVGVVYAIWSGAGIVLVATVGYFVYGQRLDLPALVGIGFILTGVMIVNLLSK
90 UniRef50_B4V939 SMR-type multi-drug efflux ... 83 3e-15 1 48.6% 1:105 1:105 MAWLLVIVAGILETGFAVCLKLSHGFTRMWPTVAFACFALGSFGLLTLALKKLDVGPAYAVWTGIGAAGTAIYGMVFLGDLVSTLKLVSISLVILGVIGLQLSGS
91 UniRef50_C4L2G1 Small multidrug resistance ... 83 3e-15 1 48.5% 2:104 7:109 -AWISLLFAGLLEIVWATTMKLSEGFTVLGPTLWTIVLLILSFGLLAKAFRTLPAGTGYAVFTGIGAVGTVIVGAFLFDEGLNGWKLILVTTLIVGIIGLKQVT-
92 UniRef50_UPI0001C3137A small multidrug resistance ... 82 4e-15 1 45.9% 1:98 1:98 MSWVYLLLAGAVEVVWSQSLKPTDGFTRLGPSIVALVLGGTAVYLLTLALRDLPTGTGYAVFTGIGTIGAVSLGIALHDDPVTAGRLGAIALIVAGVL-------
93 UniRef50_A1TK30 Small multidrug resistance ... 82 4e-15 1 27.3% 3:101 10:108 --WLFLLAAVASEVVGVTTMKLVAQEHDWGALLFMYSTIGLSFAFLAMAMKQIPMAVAYATWETLGLLAIAFIGYRYFGESMSAGKLLGMSVLIVGVVLVN----
94 UniRef50_B7H9G3 SugE protein n=13 Tax=Bacil... 82 4e-15 1 41.3% 2:105 129:226 -AWMYLVFGGLIEIYWATGLKTNS------MSILTLIAILVSFNLLIEATKKIPIGTAYAVFTGIGTVGTILVDILYFKEAFSLIKILLVCLLALFIIGLKFSGD
95 UniRef50_Q2LGR2 Membrane transporter of cat... 82 4e-15 1 31.7% 3:103 4:104 --YLYLSGAILAEIVGTTSLKFADGFTNQGPTAVVVVAYLCSFYFLSLTLQQIPIGLVYATWSAVGIVGTVAVGVVAFDESVDLAGVVGLTLVVGGVLVLNLF--
96 UniRef50_UPI0001BCD79E quaternary ammonium compoun... 82 5e-15 1 44.8% 1:105 25:129 MAWIVLIVSGVLEAVWATALGRSEGFTRLAPSAVFAVALALSMAGLAWAMRDIPVGTAYAVWVGIGASLTVVWSMSTGGETVSAVKIALVLGLVGCVVGLKLVGD
97 UniRef50_B0BRT3 Possible drug resistance pr... 82 5e-15 1 29.1% 3:105 4:106 --WVLLGFAIVIEVIGSNCIKASEGFSKPLPTAVAIGAFVIALYLLSVITKTLPIGIVYAVWSGVGIVLTAIVAYFAFGQKPDLAGFIGMGMIIAGVLVINLFSK
98 UniRef50_D0M498 Spermidine export protein m... 82 5e-15 1 27.5% 4:105 6:107 ---LFLLLAIVAEVAGTSTMSFIGQGHGWLGYIVMYVLIAVSYYFLSIAAKKISIGVAYAVWEGLGISLITVVSIVLFDSDLNTQELLGLMLAVIGIVCVTLGES
99 UniRef50_Q5YR62 Putative transporter n=1 Ta... 82 6e-15 1 44.7% 1:103 1:103 MSWLLLAFAGLVEIAWSQSIKPTQNFTRPLPTLLCFALAATAVYLLSLAMRTLPVGTAYAVFTGIGAVGAVGLGVVVHKDPLSAGRMMALALIVGGIVLARLT--
100 UniRef50_A8GZ62 Small multidrug resistance ... 82 8e-15 1 28.8% 1:104 1:104 MSWIFLLLGVVAEVLSHVALKATDGFSKPLPAALVILGHLTAFIFLGQAMKGMPVGVVHALWAGLAIVSVTLISALFYREHLDMTAWIGMVLVAAGVMMINFSQ-
101 UniRef50_Q9K106 Multidrug resistance protei... 82 8e-15 1 38.2% 1:89 3:91 MHWLFLTVAILSEVCGSSMLKLSGGFSKLWPSIGVVVSFSVCFWALSMTLKTMPLATAYAIWAGVGLVLTALVSVVFFGEKADFIGIVS----------------
102 UniRef50_B0R6K7 Small multidrug export prot... 81 9e-15 1 33.3% 16:105 17:106 ---------------GTTALKLSEGFSNPAPSVVVLVGYVSSFYFLGLVLEELPVGVVYGTWAAVGIVATALVGVVVFEESVDVAGVVGLALIVAGVVVLNVASD
103 UniRef50_A6V7W0 Probable drug efflux transp... 81 1e-14 1 31.7% 2:105 3:106 -SWIYLLLAIGAEVIGTTSMKLAATHAPVAGLLLMYGMIGLSYFFLALAVKRVPVGVAYALWEGIGIVLITAVSVAWLGESIGLYKAVGLGVMIAGILLIKSGTR
104 UniRef50_A3Y8S2 Putative uncharacterized pr... 81 1e-14 1 28.2% 2:104 3:105 -GWTLLIIGIAFEVAGSLCLKLSHGFQNFVPTIFCFFFFALALSMINLSVKTLEISIAYAVWSGAGIVIITFIGTIWFAEQFSLAKFAFISLILIGVFGLHQVS-
105 UniRef50_Q4HSV7 SMR drug efflux transporter... 81 1e-14 1 22.1% 2:105 4:107 -AWIFLMLAIVCEVFGVSVMNYSQEGNQIFVYGFMFAMIGVAYYFMSLSIRTISVGVAYAIWEIVGLSLITLIAVFIFGTSLKTQEYIGLALAIVGIVLVNLGEK
106 UniRef50_Q2B539 Small multidrug resistance ... 81 1e-14 1 36.0% 1:86 1:86 MSWFYLVLAGFGEIGFVIFMKLSEGFTRKKYTLLSGLSGFISFYFLSRALLEIPIGTGYGIWTGIGAAGSVLLGMLFFGESRDWKR-------------------
107 UniRef50_Q65JB1 Multidrug resistance protei... 80 1e-14 1 32.4% 2:103 4:105 -GYIFLLIAILSEAAAAAMLKISDGFARWQPSVLVVIGYGLAFYMMSLTLQVIPLSLSYATWSGAGTVLTAIIGVLWFQEKLNRRNIAGIICLVSGVVLINLS--
108 UniRef50_Q7VRQ1 EmrE protein (Methyl violog... 80 2e-14 1 29.8% 1:84 1:84 MDYLYLFIAIISEVIATTFLKVSDGFNKLYPIIIVILGYTLSFILLSLVLRTIPMGIAYSCWAGLGIIFITIAGYLFYDQKMDI---------------------
109 UniRef50_C5EYS4 SugE protein n=3 Tax=Helico... 80 2e-14 1 39.0% 1:105 3:104 LGWFCVILGGILEIFWVSGLKYS---TSLLAYIITGILVFCSFSLMIIATKKIEVSIAYAVFVGIGAAGVALSEIVVFGASTSPLQLTFIALLILSVIGLKLASK
110 UniRef50_C6VLY3 Quaternary ammonium compoun... 80 2e-14 1 25.0% 2:105 4:107 -AWIQLVIAIGVEIAGTSLLKLSAGFKYPLVGIVGMLLYGLAIFSFSRALSKIPLSVGYAIWAGVGTAATGLIGIWAFGEILTGLKTLGFMAIITGVILLNMPAK
111 UniRef50_Q1AZC1 Small multidrug resistance ... 80 2e-14 1 41.3% 1:104 1:104 MAWLALFVAGLFEAGMVVGLKLSEGFTRLWPGLLVLVSGGLSFFLLSLAMRTISAGTAYAIWTAIGASGAVLVGILVFGEPADLLRLGGIAFVLVGVLMLRFAE-
112 UniRef50_Q0ALZ3 Small multidrug resistance ... 80 2e-14 1 51.0% 3:104 8:109 --WTLLVLGGICEMGWALGFKYVRSDAPWWQHAAVLAVLAASMALLWMAMKSLPAGTAYAVWTGIGALGVATLGILVFNEPATHMRLFFLALILVGIIGLKAVS-
113 UniRef50_B1J7X5 Small multidrug resistance ... 80 2e-14 1 31.1% 3:105 23:125 --WLLLGVAILGEISGAISLRFSEGFTQLFPTAVALASFALALYLVSRVMRTLPVSVAYPVWAGVGTAGVTLIGVLELGESLGALKGLGVVLVVAGVVILNIASE
114 UniRef50_C7MRM1 Cation/cationic drug transp... 80 3e-14 1 33.0% 3:105 4:107 --YVLLAAAIAVEVTGTVSLKYTDGFTKLLPSALVIVSYGTAFYLMSRILkgMPVGVVYAIWSAAGVALVALIGTLFLGERMNPTMILGLILVISGVVLLELGGE
115 UniRef50_A7GSM8 Small multidrug resistance ... 80 3e-14 1 41.3% 1:104 1:101 MAWIYVILAGIIEIFWVIGLKHAE---APLEWIGVVLIIAMSFILLFKAYKDLPVGTVYAVFTGIGAGGIVLTEIFIFGEPVSIVKILFIALIFVGVIGLKQVT-
116 UniRef50_C8PBG7 Multidrug transporter EmrE ... 80 3e-14 1 26.7% 1:105 1:105 MGYVELILAIIFEIIATAFLKLSNNFTNVWYSFGTIISYCLCYYLFSLSLKSIALGVAYATWCGVGIIFTGIVSYLLWHESFPLPKLIGIILIIIGVVLCNLVSS
117 UniRef50_B7FVJ0 Small multidrug resistance ... 79 3e-14 1 26.0% 3:102 123:222 --WLVLLASITIESFATSLSKVARDSSSLQVFLGACTLYLSSMCGFAICLAKIEVGIAYAAWAALGTAFVTASGILFFQEDCDAVKVSCLFMILAGVVGLNL---
118 UniRef50_B1KCF4 Small multidrug resistance ... 79 4e-14 1 45.5% 2:102 27:127 -AWSIVVASGLLEVVFSVTMKLSDSYSKALPGGISIVAAVLSVWLMSLTLKILPLGDAYAVWAGIGAAGTALVGIVWFHEPVLLGRLFCIALVVVGIVGLQL---
119 UniRef50_C4L6W3 Small multidrug resistance ... 79 4e-14 1 32.0% 2:101 3:102 -AYLLLFFSIGFEVLGTSMLKLSDGFTNLVPSVILLVSFAASFTLMGIVLKTIPLSIAYSIWAGLGTVATGLIGVFVYGEVLSALNGIGLLLIVLGVIVMN----
120 UniRef50_B7ILV1 SugE protein n=13 Tax=Bacil... 79 5e-14 1 39.4% 1:104 1:104 MAWIYLIIAGLFEIVGVIGIKKVAKNNSWTNNIILIGGFIISFQFLTMALQEIQLSIAYAVWTGIGTLGAAVVGILFFQEPKNAFRIICIVGIMGTIIGLKVVS-
121 UniRef50_Q9RVM2 SugE protein n=2 Tax=Deinoc... 79 5e-14 1 40.4% 2:105 12:113 -AWGWVLLAGLFEVGFTYALKMSQHDGKYLG--LFLLCAIVSFECLAQALKTLPVGLAYAVWTGIGSVGTILVGLVLFGDSLSALRLGLLTVLIGSIAGLKIVDR
122 UniRef50_A0Q622 Putative membrane transport... 79 5e-14 1 25.0% 1:100 1:100 MPYIYLTIAIIAEVLGTVSLPLCNGFTKIVPSLFVLIFYGLSFYFLSLSLKSMNIAFAYSIWSAFGIILIGVIGYLFFKQRLDLPFVLGTLFILAGTIII-----
123 UniRef50_Q65KV1 Multidrug resistance protei... 79 5e-14 1 38.1% 1:105 1:102 MRWGSVILAALFEIGWVMGLKHADS---ALEWICTAAAVVMSFYILVKAGEKLPVGTVYAVFTGLGTAGTVVCEIALFNEPANIAKLALIGVLLCGVIGLKLVTN
124 UniRef50_B8J250 Small multidrug resistance ... 79 6e-14 1 31.1% 2:104 8:114 -HWLCLMGAIIFEVAGTTVMKMAQGWgaMLGLVLMWLAIALSYYMLAKATTGLPVGVAFAFWEGLGLTFITICSVLLLGESMTVTRGLGLVCVLAGALLVHHGT-
125 UniRef50_Q5HWG2 Multidrug resistance protei... 79 6e-14 1 25.0% 1:104 1:104 MEWFYLFLATACEIFGVVIMKELVNTKNKLYFLALIVCFGFSFTFLSLSMQNIAMSVAYAIWTGAGTAGGVMIGVLFYKESKSFLKLFLITVIIACTVGLKFLS-
126 UniRef50_B6ER32 Quaternary ammonium compoun... 79 7e-14 1 37.3% 1:83 1:83 MGWLFLLLAVASEAVSHVALKATDGLSHLIPNVIVITGHLGAFYFLSQAMKTLPVGVAHASWAGLAIVAVTLISNVFYHQHLD----------------------
127 UniRef50_Q4ZTD7 DMT superfamily multiple dr... 78 7e-14 1 22.1% 2:105 13:116 -AYLFLLAGIVAETVATIALKESNGFTRWVPVIASIAGYGLGIVCLGYAQRDLPMSLITSMWSGLGITLITVIAAFRYQQVPTLMAIGGISLIIAGIILVNLAKE
128 UniRef50_C2AT36 Cation/cationic drug transp... 78 7e-14 1 29.4% 4:105 7:108 ---ILLFLAIVCEVAATLSLRATDGFKNLWPLLIVVPGYIGAFAFLGLSLREISVGVAYAIWSAAGTVLITVGAAVLFHDRISWVTMVGMAVTITGVVIINLSGS
129 UniRef50_C2LWZ1 SugE protein n=3 Tax=Staphy... 78 7e-14 1 33.3% 1:102 1:102 MAWLYLLVAGCFEILGVVFLNELNRTHKKIYILLGAITFIFSFSTLKLSMQTISMGTAYAIWTGIGTAGGTIVGMIFYNESKKFIRIFCIALILISVIALKI---
130 UniRef50_D0S951 SMR family efflux pump n=1 ... 78 8e-14 1 27.6% 1:105 1:105 MAFLYLLIAVIAEVLATSALKATNGFTAPLPVVLTIVGYAIALFFLGLTFKSIPMGLAYALWSGAGIILISTVGWIYFKQQLDFAAVVGLSFMIIGIVIIHVFSK
131 UniRef50_Q3SPD9 Small multidrug resistance ... 78 9e-14 1 29.8% 2:105 3:106 -AWGLLAISIVAEVTATTLLTKSEGFGKPVYGVAALAIFAGCFWALSQVLTRIPVGVAYAIWSGAGVVLISLIGAIFLRQSPSMIQILFISLIVVGAVGLNLTTS
132 UniRef50_C1EV95 Multidrug resistance protei... 78 9e-14 1 28.4% 3:104 4:105 --WLLLLVTIIFEVAGTIAMKLSNGLTKLVPSVLIFVFYGICFSVFAIVVKKIHLSIAYAIWSGVGTLLITIISVYFFKEHISLFQACCILFIVLGVIGLKVSS-
133 UniRef50_C3MCJ4 Putative multidrug efflux s... 78 1e-13 1 24.3% 1:103 3:105 LAWLFLGLAIATEVVGLTVMKAASMSTAYVGHAVMYASIALSYVFLARAVKTIPVGVAYAIWEGSGVALITLVSVFVFNHVLSGREILGLSMAVAGILLVNAG--
134 UniRef50_A6U978 Small multidrug resistance ... 78 1e-13 1 30.1% 1:103 3:105 LAWFFLVLAIVTEVVGLTVMKAASGSGTYWGHIIMYASIALSYVFLARAVKVIPVGVAYAVWEGSGVAVITLVSVFAFGRALSGREMLGLAMAVAGILLVNAG--
135 UniRef50_Q30YP3 Multidrug resistance protei... 78 1e-13 1 27.9% 2:105 8:115 -HWLCLTGAVFFEVAGTTLMKASQsfGAEAGVVIMLLFIGVSYYLLSLSTTALPVGVAFAFWEGVGLAFITLASVFILGEQMSLLRFAALCAVLGGVLLVHHGTS
136 UniRef50_Q8ELG4 Chaperonin n=2 Tax=Bacillal... 77 1e-13 1 39.0% 1:105 1:105 MNWIILILAGLSEVVGVNGIQKVSAGKKKSGFAFLIIGFAVSLTLLSIAMSTIPLGVAYAVWTGMGTVGSVVIGMIFYNDSADRKRIFFLSLIVVAVIGLRIVSN
137 UniRef50_B1M6K5 Small multidrug resistance ... 77 1e-13 1 36.7% 3:100 4:101 --YLILGLAIGAEVTATLALKAAEGLTRPGPTVIVALGYGTALWLMSTSMDMLPIGVVYAIWSGIGMIGAAVGGAWLYGEAINPTMLVGIGVIAVGVTIL-----
138 UniRef50_A4XPW5 Small multidrug resistance ... 77 2e-13 1 28.8% 2:105 3:106 -GYLYLAIAIAAEVVATTSMKAIDGFSKPLPLLLVVGGYAIAFWMLTLVVRTIPVGIAYAIWAGLGIVLVSIAALFLYQQKLDLPAVLGMGLIVSGVVVIQLFSQ
139 UniRef50_C7RU42 Small multidrug resistance ... 77 2e-13 1 30.8% 1:104 1:105 MTWLILFVAICAEVMATTAMKLTDGFKKIWPWAFVMacFGLALYLLSLTLDTLPVGPVYAIWSGSGVALITIVGQVVFKQVMDRPALIGIVLIVAGVVVLQVFS-
140 UniRef50_B8HHF7 Small multidrug resistance ... 77 2e-13 1 36.4% 3:101 8:106 --WLVLLASAVLEAVWATALGLSDGFSKPLPTMVFLVTATLSMLGLGMAIRSIPLGTAYAIWVGIGAALTVGWAMATGVEPFSVLKLLFIAGIVGCAAGLK----
141 UniRef50_Q1D1W2 FrdD homolog SocA2 n=2 Tax=... 77 2e-13 1 44.8% 1:105 1:105 MAWIVLILAGCLEIAWALALKRADGLTRFWPSVIGIGLAMVSLVLLSLALKQLPVGTAYDVWVGMGMCGVAVFGMLFLGEQVSAPRIFFLVMIGIGVAGLRAIER
142 UniRef50_A9VGF9 Small multidrug resistance ... 77 2e-13 1 30.8% 2:105 5:105 -AWLYVILTCIFEIFWVFGFNTAHT---WWHWVIIVGVIAVDFYFLSKACEHLATGTVYAVFAGAGTVGTFLMDVFLFGGSFSVGKLFFIVMVVAGVIGLKLADN
143 UniRef50_D2BQS0 Quaternary ammonium compoun... 77 2e-13 1 25.7% 1:105 3:107 LGYLFLAIAIVSEVTGSSLIKYTEGFTKPLPSIFCMALFGLAIFMLSKTVNYIPLYIAYALWGALGIILVTLISIFVMKESVNIATILGLFFIVIGVVLVNIYGS
144 UniRef50_Q1V234 Small Multidrug Resistance ... 77 2e-13 1 26.5% 3:104 5:106 --YLFLTIAIFCEVGGTMLLPVSQNFTKIIPTTTLAILYLSSFYLLTFVVDKLPIAIVYATWSGLGIFTIAILGYIFFKQSLSWQAVLGLFFIVTGVVLVNSFT-
145 UniRef50_A5FEQ2 Small multidrug resistance ... 77 2e-13 1 45.7% 1:105 1:108 MNWIILIIAGLFEVAFATClkETAGMEMYYWYIGFFASLTISMLLLIKATETLPMGTAYAVWTGIGAVGTVLMGIFVFKEPATFWRLFFLVTLVSSIVGLKAVSH
146 UniRef50_C0WZX0 DMT superfamily drug/metabo... 77 3e-13 1 23.5% 1:102 1:102 MGYALLSLAIGFEILGTNLLKLSVGFTRVGIGITSLACYGVSFYLMALSYQKLPLSVAESIWAALGIIAATLLGQFVYHERVALAQWLGVRLIIVGVLLVSF---
147 UniRef50_Q1MPU8 Membrane transporters of ca... 77 3e-13 1 31.1% 2:104 12:118 -HWIYLIIAILLEVIGTSVMKLSQLGTWiiGYLLMLICIGLSYYMLALAATGLPIGVAYAFWEGLGLILITLVSIFVIDEKMTITRLISLFALLSGAILIHHGT-
148 UniRef50_B2UPI1 Small multidrug resistance ... 76 3e-13 1 42.7% 1:103 1:108 MSWIYLVLAGLCEIGWPLGFKLSqgPGKFAACIACSVfmVLSGFLLWLAQRNIPIGTAYAVWTGIGALGTFLVGILWFGDSSNIWRMLAASFLLIGIIGLKLA--
149 UniRef50_A0QKK8 Multidrug resistance protei... 76 3e-13 1 47.1% 1:104 1:104 MAWLILIASGVLEAVWATALSRSEGFSRLGPSLVFFVALAFSMTGLAVAMRSLPVGTSYAVWVGVGAALTVTYAALVGDEPASPVKLVLIAGIVACVAGLKLLG-
150 UniRef50_UPI00017885A1 small multidrug resistance ... 76 4e-13 1 37.5% 1:104 1:104 MEWIALIAAGLCEVLGVIALRRVTLQRSLGSYVFLACSLGSSFLLLTYAMNFISMGTAYAIWTGMGTAGSTLLGMFAFGEPKEWRRMFFIALILASAIGLKIMT-
151 UniRef50_C4XT44 Putative small multidrug re... 76 4e-13 1 42.7% 1:103 5:108 MAWTYLIVGGLFEAGWPIGLKMAETPGrlAGWLIATLCMAASMALLYLAQREISIGTAYAVWTGIGAAGAFACGLLLYGDPATFGRFAGVGLIISGVVVLKLA--
152 UniRef50_C7Q742 Small multidrug resistance ... 75 5e-13 1 41.9% 1:105 1:105 MAWGYLLIASVFEVVFALATDATHGFTVLGPSLLTVAAAAGGIFFLSLALKTLDVGVGYTVWTGIGSVGTVVFGTALFHEAVTPAKVIAFVLIIGGVLGLKVADK
153 UniRef50_C8WD50 Small multidrug resistance ... 75 5e-13 1 27.2% 2:104 4:106 -GWTGLAIAVFFEVAATTALRLANGIDKPLWLITACIGYFICFTIISFVFKTLPLGIVYAVWAGGGLAIMTIVSQWIFNETLDLRQIGCIALILIGVIGLNLIS-
154 UniRef50_C3XES6 Multidrug resistance protei... 75 5e-13 1 30.8% 1:104 2:105 LHWILLFIAGVFEIAGVWTMKKLIDTKNKIYILCLALIFAGSFTCLSIAMREISMGVAYAIWTGIGAAGGVLVGIVFFKEDKSFLKLFCVCVIIASSVGLKALG-
155 UniRef50_C4L2G2 Small multidrug resistance ... 75 5e-13 1 31.7% 1:104 1:104 MSWVYLIGAGIAEMTAVFFMGKSKGYQILKWSIASILSFALSFYWLSKSLEVIPLSLAYSIWVGIGAAGGVILGMLYLNESKSRWRIFYLTLIIGSVVGLKVVA-
156 UniRef50_Q7VIU5 Predicted efflux protein n=... 75 5e-13 1 23.3% 2:104 6:106 -SYLFLMFAILTEVLAVNLMKASEG--EIWGLMCMYVLLVLSYYFMALSLKRISVGVAYAIWEVLGAICVVCISVFYFGEEISFIQKIGIVLSISGIALINYAE-
157 UniRef50_A8FTF4 Small multidrug resistance ... 75 6e-13 1 31.1% 2:104 4:105 -SYLYLAIAIISEVIATTLLPITMGFTRILPSLACVIGYGSAFYFLSLATAHIPTAVAYAIWCGAGIVLIALIGAL-QGNMPNLDTIFGMVLIIIGVSLINMNT-
158 UniRef50_A3Z6D7 DMT superfamily multiple dr... 75 6e-13 1 28.7% 1:101 2:102 LGYAVLIAAILFENIGTTALKGSNGFKRPVLGSVAVLGYILSFAFMGQALARLPLAIAYSIWCGLGMSVVTLTGILVYKEKFGWKVALGLLLIFSGVMISN----
159 UniRef50_A9QS71 Multidrug resistance protei... 75 7e-13 1 46.2% 1:104 12:115 MTWIYLLIAGTFEVAWATTMKLSHGFSNLKFTLLTIIGMIASFGFLALALKKLPLGIAYPIWTGIGAVGSILIGLILFKDKVPPLTWLFIACLVVGIIGIKVTS-
160 UniRef50_Q0VLF6 Small multidrug resistance ... 75 8e-13 1 42.3% 1:104 3:106 LYWVVLLLAVIVEIAWAMSLKWIQLSPGVLSIGTSLVLTGLNMLMLSYAMRGIPVGTAYAIWTGLGAVGITLIGIVFFKDPANASRLAFMALIVVGIVGLKLTS-
161 UniRef50_A1WS30 Small multidrug resistance ... 75 8e-13 1 53.1% 42:105 57:120 -----------------------------------------ALSMRTLSMRTLPMGTGYAVWTGIGAAGTAIVGMVVPGDSAAPMRLPCIALIPAGVIGFKRVTS
162 UniRef50_Q2J9I9 Small multidrug resistance ... 75 9e-13 1 35.6% 1:104 1:104 MRWLLLLGAIGSEVIATSALKMSDGLSRLTPTVIVGVGYLAAFILLGKAIKQLEVSTAYAIWSGLGTAAICLIGAFAFGESLTAAKTVGVLLVIGGVVVLNLAG-
163 UniRef50_A0B420 Small multidrug resistance ... 74 1e-12 1 34.0% 2:104 14:116 -AWFVLGLSVIAEVFGTIGLKFSSGFTHLPSSVFTVVCYAGAVWLMSITTLNVEVGLAYAAWAGASTAITAGLGILLFGESVSVSKLCGLAMAAGSLVLLNLSD-
164 UniRef50_D1V929 Small multidrug resistance ... 74 1e-12 1 35.1% 12:105 14:107 -----------SEVTATALLPRAEGFKDPWWSAVVLLGYGLSIWLLARVVRTLSVSVTYAIWAGVGTAAVAVVGVFFLGESMGWIKTISLALIIAGVIGLNLVAE
165 UniRef50_B9YJF8 Small multidrug resistance ... 74 1e-12 1 28.4% 2:82 4:84 -SWLYLMIAIVFEIARITCMKLSEELTKLVPSILIFVLYGLCLTFLTLSLRKLEVSIVYAFWSGLGTIVVTSIGIVWFRESL-----------------------
166 UniRef50_A1SEC0 Small multidrug resistance ... 74 2e-12 1 33.0% 3:105 4:107 --YLLLGLAIAVEVMATLSLRASEGFSRPLPSLIVVSGYGLSFFLLSVVlrGLNVAIVYALWSATGIVAIAVIGATFLGERLTSAQVLGMGLIVSGVLALELGAR
167 UniRef50_B4SLV5 Small multidrug resistance ... 74 2e-12 1 32.0% 2:104 13:115 -AWACLTVAIVAEVVGTSFMAHAARDGGWTGYLIMAGALALSYFFLAQSVRRIAVGVAYAVWEGLGLTLLTVVGLTVFGESLSLQQLAGLVLAVVGIVCVTLGE-
168 UniRef50_Q2J8Y7 Small multidrug resistance ... 74 2e-12 1 31.3% 7:89 4:86 ------IVAIVLEITGTLALRETSGFTRLWPTLMVCVCYPLSFFFVSRVLQHLEIGFTYAVWSAAGTAAMAVIGAAVFGESMNALKVAS----------------
169 UniRef50_C6VLY4 Quaternary ammonium compoun... 73 2e-12 1 32.4% 1:102 1:102 MAYGLLFGGIFMEVLGSFFLKRANGFRNLIPTIMVLVGYFSSLVLVTLAMQRLPLGVTYAMWAGLGTFATVILAVVVYRERLSLSRLSGLIAIVVGAILLNI---
170 UniRef50_C3XES5 SugE protein n=2 Tax=Helico... 73 2e-12 1 35.2% 1:105 11:112 LAWLLILIGGICEVAWVSGLKYADT---LPLKALTGVGIACSFTCAVLAMKRLEVSIVYSVFVGIGTGGVVVAEIVLFGEEASLIKIALISTLMLGVLGLKCSVK
171 UniRef50_UPI00017885D5 small multidrug resistance ... 73 2e-12 1 36.6% 13:105 15:104 ------------EVVWVSGLKHSDV---WWQWVITIASIVFSFKVFLDSAAKLPIGTVYVIFTGLGTAGTVLVEILVFGEEANPVKLLLIAMLAAGVLGLKLVTK
172 UniRef50_C7NIW1 Cation/cationic drug transp... 73 2e-12 1 27.7% 1:101 1:101 MSWLYLAIAVVFEVAVGIAAGKANGFKHLWWTIATLASGAIATFFLSLALLTFDVGVGYALWTSLAGVGIVIVGALFLSQKLTWKKFLGILVVIGGVVGLN----
173 UniRef50_Q1ZTG8 Putative multidrug transmem... 73 2e-12 1 23.5% 4:105 6:107 ---IFLLLAIAAEVAGTSTMSLISSEGSHWGYWVMYGLICISYFFLSLAAKKIAIGVAYAVWEGLGIALITLVSVFVFDAQLNTQQLIGLAMATVGIVLVTLGEE
174 UniRef50_Q1R1D7 Small multidrug resistance ... 73 3e-12 1 36.5% 1:104 3:103 MRWLILPLAALAEVGWATGLKLA---SSPLEWLATVIVAAMSLLLAVRAVRFLPASTVYTVFVGLGAAGTVVADAWLFGTRFSWPSLACIGLILVGVIGLHQFS-
175 UniRef50_C1D7D5 YdgF n=1 Tax=Laribacter hon... 73 3e-12 1 29.1% 3:105 4:106 --WLYLAAAIAAEVTGTSLLKWGADTGNLLGLAAMSVLLAFSFYMLSLAVVRVPVGVAYAVWEGIGIIIISIVGYWIFDERLSLAKTLAMLSIIIGITLMKRGTD
176 UniRef50_UPI0001C33EFE SMR family multidrug efflux... 73 4e-12 1 21.0% 6:105 10:109 -----LIAAVSIEIIATTLLSLSNSFQRPTIGMTAILFYGISYYFLSVALRRIHIGVAYAIWSAVGILSITYIQTRCFDYILTQSAWIGVCLVISGTIILNLAIK
177 UniRef50_Q1V2I6 Quaternary ammonium compoun... 72 4e-12 1 27.9% 2:105 6:109 -GYIFLVLAIILGISSNGFLKATEGFTNIYPTIFCIITIVACIFCLSKAMTIIPVGFTYATYGGLTITAVTIFGVVKYNQTPNLYAVLGISLIIIGVILLNTMGK
178 UniRef50_C7JHM9 Quaternary ammonium compoun... 72 4e-12 1 22.0% 2:101 3:102 -GFLYIFFTVISEVVGTAALKETQNFTKPLPICVMSIGYVLSFLFLSLALKITPMSVVYSVSSGLGIVFSCLISRFYFNQSLDYSQILGIVLIFFGVLLSN----
179 UniRef50_A0QYI6 Transporter, small multidru... 72 6e-12 1 33.7% 1:104 1:105 MMWLALAGAILVEVVATLSLRASDGFRRRAWIVPVVIGYAASFYLLWVALsgVPVGVAYGIWTACGVALVAVVARILFRDPLTPMMMLGIALIASGVFTIELAG-
180 UniRef50_B6BQJ8 Quaternary ammonium compoun... 72 6e-12 1 33.3% 2:85 6:89 -AYILLAVAIAGEIISTGTLKATDGFTKWVPSLICILAIAICMYTMSHAMKILPIGITYATWSGVGIIALSLIGIFKYKQIPNLA--------------------
181 UniRef50_A0KNZ6 Multidrug resistance protei... 72 6e-12 1 25.7% 4:104 11:112 ---IFLTGAILTEVAGTSSMAMieNEAGWLNYLPMWLLISFSYLLLAKAAKTISIGIAFALWEGLGIALITVVSVLFLDYHLNAQELIGLALAIVGIVLVTMGE-
182 UniRef50_A7ZM58 Spermidine export protein m... 72 8e-12 1 31.3% 5:103 11:109 ----WLALAIVLEIVANVFLKFSDGFRRKIFGLLSLAAVLAAFSALSQAVKGIDLSVAYALWGGFGIAATLAAGWILFGQRLNRKGWIGLVLLLAGMIMVKLA--
183 UniRef50_Q4L8G2 Similar to chaperonin prote... 72 8e-12 1 42.9% 1:105 1:102 MQWLKVILAGLIEVIWVIGLNNAHNFVTW---LFTLVFIALSFYLMISASKQLPVGTVYAVFVGIGAAGTVIADMLFFGEPFTIMKVVLLLLLLVGIIGLKLSTN
184 UniRef50_B9IR74 SugE protein, putative n=78... 71 9e-12 1 36.5% 1:104 1:104 MGWFFVFCAAISEIVGVIGLKMYSKDKTLANGALYIGGFATSFAFLYTSFLFLQVSVAYAVWIGIGTAGAVLLNMFLFGESKSKARIISVALIVCGVTGLKALS-
185 UniRef50_Q9KEL2 Multidrug resistance protei... 71 1e-11 1 33.7% 1:104 1:105 MAYLFLSFTILTEVIGAISSRYSEGFKKFIPSVITFIVIIASYYFFAVSLQylNIGIGYAIWSGVGVSVITCFGFVFLKESVTKVQLLGIVLIVVGIVTLEFGG-
186 UniRef50_C2BKZ5 DMT superfamily drug/metabo... 71 1e-11 1 28.8% 2:105 3:105 -AWVILFLAIATEVLGTVALKYA--VDHFWIYGVAALCFILAFVLLHRVMqgVNVGVAYGLWASGGVISTALLSAALFGEPLGAVKLAGIALIMGGVFCVEMGAK
187 UniRef50_UPI0000510169 putative multidrug resistan... 71 1e-11 1 22.3% 1:103 1:104 MSWFWLLLSVVCEVGATLSLRASVGMHWKRWLIPVGAGYALAFFFLSLTLagMPLGVAYGLWSATGVVLVCLLGRVIWKDPLTRRMMLGIGCIVVGVILVELG--
188 UniRef50_C6IWF0 Small multidrug resistance ... 71 1e-11 1 40.0% 1:105 1:105 MDWILLVFAGFGEVLGVIGINKINTRKSLGAYAWMAGGFLLSFLFLTLAMRTISMGTAYAVWTGIGTAGSAIAGMLLYGESREWRRLLFIAFILGAAVGLKLISE
189 UniRef50_B8GFT6 Small multidrug resistance ... 70 2e-11 1 43.0% 25:103 23:96 ------------------------GFTRPFPTLITLVTMGLSVYFLSLATRSLPLGTAYAVWTG-----TVIAGMILFNEPRGLARFLCILLILAGIAGLNLT--
190 UniRef50_C5F224 SMR drug efflux transporter... 70 2e-11 1 24.5% 4:105 6:107 ---VFLLLAIFCEVFGVSVMNYAGGENKILIYGVMFLMLGISYYFMSLAILRISVGTAYAIWEILGLSLITIISVFIFENHLNLQEYIGLGLALLGIILVNLGEE
191 UniRef50_C4VN10 Multidrug resistance protei... 70 2e-11 1 28.8% 1:104 1:104 MGYFYLAIAIIGELIGTTLLKMSQGFSKWGIGIVALIAYVICFYFFSKSLKIIDLGVAYAIWSGVGIVITTIIGIIIWKEKVNLITILAITMIIIGIMLLNLMS-
192 UniRef50_B9DT41 Putative quaternary ammoniu... 70 2e-11 1 27.6% 1:105 1:105 MAIVYLLLAILAEVIATSALKLTKGLTLLWPSLFCISIYMICHYYFAKAIQDLNLGIAYALWCGVGILVTVFVSVLFYKESLSVTGILGILLILSGCLLVNLGGN
193 UniRef50_B9E792 Putative uncharacterized pr... 70 2e-11 1 31.4% 1:105 1:102 MNWIKLILAALFETGWVIGLAHADS---AFEWMLTLVSVTFSFYLLLNATKYLPVGTAYAIFVGLGATLVTIVDVAVYEVPLGWPKVVLITMLIIGVVGLKFATE
194 UniRef50_Q1GVX5 Small multidrug resistance ... 70 2e-11 1 44.2% 1:104 1:104 MGWIILAIAVFTEICWALSLKWAATLGTWQASIVPIALSFLNMALLALAMREISAGTAYAIWTGLGAVGVIIGGTILFGEKISPMQAGFMVLIVVGVAGTKLFA-
195 UniRef50_Q8CNB9 SMR-type multidrug efflux t... 70 3e-11 1 36.5% 1:104 1:104 MAWLFLMIAGSFEILGVVLLNELSRTKNKIYVIFLGLAFILSFSTLKFAMVSIPMGTAYAIWTGIGTAGGTLIGMIFYGESTRLSRILCILLIIISVVGLRLIS-
196 UniRef50_Q1V2I5 Multidrug resistance protei... 70 3e-11 1 27.9% 2:105 6:109 -SYLFLALAVVLGVASNSFAKSAEGFTLLVPSIITAITIVLCMYALSMVMKNIPMGITYASFAGLAIISTVGVGIIKYNQVPNLYSIVGLCFIIVGVLMVNLLGN
197 UniRef50_B4RXI9 EmrE protein n=2 Tax=Altero... 69 4e-11 1 25.0% 1:100 1:100 MTYLLLAIAIVTEVTATLLLKMSNGWEKWAFGYGAIFFYTVSGMLFAMVLKNMGIGVAYAIWSGMGIALITAASVVFWKQTFDIYAVLGIMLIISGTLLI-----
198 UniRef50_C6W7W9 Small multidrug resistance ... 69 4e-11 1 33.0% 1:100 2:102 LKWFLLSLAVCSEVFATLCLKASHGFTKPLPVLGLVVGYGIAFYLEAQVIrgLPVAITYAIWAGGGIALVAVAGRVLFADPIAPGTLAGMALIAAGVGLV-----
199 UniRef50_C6X2X5 Small multidrug resistance ... 69 4e-11 1 37.1% 1:105 1:112 MNWIILIIAGLFETGFATCLGKAqgRESYFWWAGFAASLFISMFLMYKAISviPIGTAYAVWTGIGAVGGVMAGIFIFNEPATFWRMFFVFTLIASVVGLKVVSN
200 UniRef50_Q9KEL1 BH0841 protein n=1 Tax=Baci... 69 5e-11 1 27.6% 1:105 1:106 MSYVYLFLAIFLEVTAAISTRFSEGFTRPSISAVVVVFAVASYVLFSLSLKhmNIGIGYTIWSGVGVLTVALIGVVFLDDFLTIIQMGGIVLIMIGLGAVQLGGE
201 UniRef50_Q1IWY3 SugE family protein n=1 Tax... 69 5e-11 1 32.2% 15:104 19:108 --------------FANLLLKASDGFRRPLPGLAALTLVLCAFGLLGLSLHTVPLSVAYAVWGGLGIIGAALLSRRLEGVRFTPRAWLGLALILGSVAVLHLAE-
202 UniRef50_A4F9R2 Small multidrug resistance ... 69 5e-11 1 27.6% 1:105 1:106 MAYLLLLGAVASEVVAALATRFSAGFTKLVPSAVAITGVVGAYYLLSLALkgMDMGVAYGIWAALGVTAVALVGAAFLGDTLTWAQMIGIVLVIGGVLSLELGGQ
203 UniRef50_P69927 Multidrug resistance protei... 69 5e-11 1 32.7% 1:104 1:105 MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAFALLALSIShmQTDVAYALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGLIVVGVVTLNLAG-
204 UniRef50_D1A404 Small multidrug resistance ... 68 6e-11 1 34.6% 1:104 1:104 MPYVLLGLAIIAEVTATLSLRASEGFSKWGPSVIVVVGYALSFLLLAKALTALNVGPVYAIWSALGTIGAFAGGVLLFNEPVRPVTVLGAAIVVAGVVVMNLGG-
205 UniRef50_C1YFW9 Cation/cationic drug transp... 68 7e-11 1 31.4% 1:105 1:106 MAWFFLVATVVTEVLGAFATRASDGFTAPVPTVLAVVSVVAAYYLFSLALRhmPVGVAYGLWTALGVAAVAALGVALLGEALTWPRVGGLLLVTVGTAFLQMGGR
206 UniRef50_C3XL88 SugE protein n=2 Tax=Helico... 68 7e-11 1 33.7% 1:104 1:104 MSWAFLMLAGCIEVLGVIMMKAYAVTAKKLYLLGVAFFFVLSLGSLSLALREIPMGMGYAIWTGIGTAGGVLVGIIFYKESRNFWKLFFVALIAACSVGLKLVS-
207 UniRef50_D0XK28 Small multidrug resistance ... 68 1e-10 1 43.7% 1:103 1:110 MGWISLVVAGVLEVGFTTTLRLLNGMgkIGLNVLFIGLIIASFQALQFAIRTIPMGMAYAVWTGIGAVGTVVVGALFFGERLDAVRLILLAVIVAAIVGLKLV--
208 UniRef50_Q1R1D6 Small multidrug resistance ... 68 1e-10 1 39.6% 2:102 4:104 -HWLALLGAGIFEVLGVVGFARVSRGRALAGGLLMTLGFGTALGFLALAMRGIDLGIAYAVFTGIGTVCGTLLGMLYWGESRHPLRIAFTALIVLGVVGLKL---
209 UniRef50_UPI0001C33EFD small multidrug resistance ... 67 1e-10 1 23.7% 4:100 5:101 ---FWLIISVTMEVIGTLLLPQTDNFKNKSVTLLCMVCYVMSFYALSMLMDAVTPVVAYAVWSGFGIVMIALMSSIFYQMRSSVLEKVGICCIVAGLIVI-----
210 UniRef50_B4EVU6 Multidrug resistance protei... 67 1e-10 1 27.3% 5:103 12:110 ----FLLLAVVLEIVANIFLKMSNGFSRWGLGILSLLCVLGAFSSLAMAVKGIELSVAYALWGAFGIIATIAAGWILFNQRLNYKGWSGIILLLVGMIMIKFA--
211 UniRef50_A1W0F7 Multidrug resistance protei... 67 1e-10 1 23.3% 2:104 11:110 -AWFFLITAIVFEVLGTSFLKMEN---QILGYIFMALFIAFSYFFMGKAIKKIQVGIAYAVWELLGIILILLVSFIVFKESLTLTQILGIVLSIVGIIMINIGE-
212 UniRef50_C4DHH2 Cation/cationic drug transp... 67 2e-10 1 27.7% 3:85 4:87 --WLMLGIAIALEVGATLSLRAMSGLEHPWFLAAVVAGYVGAFYFVAKLLEtmQVGVAYGVWAASGVALTAILGSLLFGDPLTWQ--------------------
213 UniRef50_Q28SV5 Small multidrug resistance ... 67 2e-10 1 43.0% 1:100 1:100 MAWVYLFIAGALEVAWATGLKKLGIGFSWTLGVLTLIAMIASIIALYAAMTRLPLGIAYPIWTGIGSVGSVLVGVLAFNQNLSWSGIAGLALLIAGMFLL-----
214 UniRef50_Q2IH18 SugE protein n=7 Tax=Bacter... 67 2e-10 1 30.8% 1:104 1:104 MSWIHLGVAVIFEIAVAISAGNARGFTRPWWTTATLVSGAIGTFFLSLALLTFDVGVGYAIWTSVAGVGVVVLGAMFLGQRLGWQKLLGILLVIGGVVGLRLSG-
215 UniRef50_B8J251 Small multidrug resistance ... 67 2e-10 1 24.0% 4:103 13:112 ---LLVVMAAALDVLANLLLAKSGGFRRRWLGFFSLVLVGLAFYCLSLAVRHMDLAVAYAMWGSFGILGTSLGGWLFFSQKLRPCAFAGMALLMTGMALLHMS--
216 UniRef50_Q39RE7 SugE protein n=1 Tax=Geobac... 67 2e-10 1 40.3% 27:103 7:83 --------------------------TRWPGIGVAVVFMAFSGLFLWMAQRQIPIGTAYAVWTGIGAAGTFLVGVHYYGDPTSIARYAGVALIVAGVATLKMA--
217 UniRef50_UPI000197A737 efflux protein n=1 Tax=Heli... 67 3e-10 1 26.7% 4:104 13:113 ---VFVLVAALLDIVANLFLKKSNSFTHKGYAIACVVMVWVAFSALAVAIQILSLSTAYATWGAIGIIGTALGGYIFFKENLGTLGYIGIAMVVCAVVLLNWGD-
218 UniRef50_Q3IFU8 Putative multidrug transpor... 66 3e-10 1 28.2% 1:103 1:104 MHWIYLIIAVTLEVIGTTVMKwvNEDQLLLGSLFVTLMVGLAYLALSQATSKIPIALANAFWEGLGMILIASVSFVFLGEAISIGQMFALLLAIIGIVIINSG--
219 UniRef50_Q1KY27 SugE transporter n=1 Tax=Bu... 65 5e-10 1 52.9% 20:104 1:85 -------------------MKQSHGFSRLLPSIITISTMVASFWLLAVAMRTIPLGTAYTIWTGIGAVGAFLVGIAFLAEPVNAARIIAAILIVSGLVLMKLSS-
220 UniRef50_C3XDD9 SMR drug efflux transporter... 65 9e-10 1 21.9% 1:105 23:145 LAWTFLIIAILLEVGGVAMLNAIPLWLEPFSsaVMLSMIAASYYCMSLALRKIALGVAYSVWEIVGMIGILFISFLFFPPNLTIKEYIGIAVGFVGIICVILGEE
221 UniRef50_O32262 Uncharacterized membrane pr... 65 1e-09 1 43.8% 1:105 1:101 MNWVLVFIAGLLEVVWASSLKHADS---LLDWIIIFILIAVSFILLIRSYQKIPMAAAYTVFVGIGTVGTYLTGIVL-GESFSAAQMFFLALLLAGILGMKLFTK
222 UniRef50_C2BKZ4 DMT superfamily drug/metabo... 64 1e-09 1 22.1% 1:104 1:105 MIWFLLFLATAIEVTGTLCLRMSAVTGRRFWVALVALCYVSAYGFLALVLkgMDLGVAYGIWAATGVALTAIASYLLFKEPFTWLKSLGVVLIVGGVLLVEAGA-
223 UniRef50_A7H2K0 Multidrug resistance protei... 64 1e-09 1 25.7% 1:101 1:101 MYIFIIVLSALLDIVSNLLLKKSDGFKHKIWGLAAIINAILAFFLLSFSLKYVPLSIAYSTWGAIGIIGTCLGGWILYKEKLNKIGILGIVIVIIAVFLLN----
224 UniRef50_Q7VIU6 Predicted efflux protein n=... 64 2e-09 1 24.8% 1:101 3:103 LAFIYVIISAILDVIANLFLKKSNVFTHKGYTIGCILMVWAAFSVLVLALESMPLSVAYSTWGAIGIIGTIFGGYVFFKEKLDFLGYIGVAMVVCGVILLH----
225 UniRef50_Q3IFU7 Putative multidrug transpor... 63 2e-09 1 24.5% 3:104 5:106 --WLYILGSVIFDIAANVFLEMSHGFKHKRFGILAIVFIMAAFALLTLAVQGIPLFIAYATWGALSISGTALATWLLFGHKLNWVVCFGLAVLILSIVTMQLVG-
226 UniRef50_B2GID5 Multidrug efflux transporte... 63 2e-09 1 24.3% 3:105 4:105 --WLYLVAAIVLEVSGSLSLKAA--MDAPQFYVIVVLGYLGAFVGLFAALrgMSLGVGYGIWGATGVAATAVLSLVIFNEPITPVMGLGIVLVIAGVLTVELGSQ
227 UniRef50_A8FK99 Multidrug resistance protei... 63 3e-09 1 24.4% 2:83 22:100 -AWFLIILGGIIECFWVSGLKYS---TEIWHYILTAIGVCISFTCFLKACERLEVSITYSVFVGIGTIGVVLNEMFIFNEAVS----------------------
228 UniRef50_B8J441 Small multidrug resistance ... 63 3e-09 1 32.7% 1:104 1:104 MSWVYLVMAGLLEIVVVAGVRDIAFRRYARGFVVYGLGLTSSLFFLYLALRQIDVSIAYTSYTGIGVIGTVASGLLFWGEKRSFRKACYVGLIVAAIVALKISG-
229 UniRef50_B5VU23 Small multidrug resistance ... 62 4e-09 1 30.3% 2:100 7:114 -GWGFLILAAINNCVGSLLLKKSrtLLLSPWFIGGIMVYGVNVILFAKALDQLPVSTAYPIFAGISFTLIAIAGNLLFGERFDLNQWIGLSLIFTGIIIM-----
230 UniRef50_B8J442 Small multidrug resistance ... 62 7e-09 1 27.7% 1:101 2:99 LSWVLLLVASGLEIAWAAGLKYAQ---QPLEWAVTLACIAGSFIFLVLATKRMEASIAYVLFVTFGTVGTYLLDVCFFDKRITLTAVTAIAVILFSIIQLK----
231 UniRef50_C0B2Z8 Putative uncharacterized pr... 62 7e-09 1 37.3% 39:105 1:67 --------------------------------------MPLPISFLAIAVKKVALGVAYALWEGIGIVIITTFSVLWFGESLSPLKLGGLAMLIAGITLIKSGTK
232 UniRef50_D0M497 Spermidine export protein m... 61 9e-09 1 29.2% 1:89 7:95 MSFGFVVMAALVDIVANMALTRSHGFKYKGWGITAIVLVLTAFTLLAQAVKEIDLAIAYASWGAIGILGTAVGGALLFKQKLKPIGWFG----------------
233 UniRef50_Q30YP4 Multidrug resistance protei... 61 1e-08 1 29.7% 13:103 21:111 ------------DVAANLLLAKSRGFTVRRYGVMALAAVGLAFVCLSFAVRSMDLAVAYAMWGGFGILGTSLGGWVLFGQKMAPSAWAGIALLTCGLAMLHIS--
234 UniRef50_A1TAE3 Small multidrug resistance ... 61 1e-08 1 24.8% 1:105 1:104 MTWLYLMLAICTEVAATLSLKGLA--TVPALYIVVVLGYVASFVFLALVLKrmGLGVAYGIWGATGVALTAVLSSVMFGEALTAVMGVGLSCIIAGVVLVESGSH
235 UniRef50_B2GID4 Multidrug efflux transporte... 60 2e-08 1 26.3% 10:104 13:107 ---------ILCEVVGTVSLRLASA-GRKVWWVGATVGYVLAFWLLAVVLShvPLGVAYGIWSATGVAITAVISRVFFKEPLTWLMCLGLSLIVGGVLCIDFGA-
236 UniRef50_C3XDP3 Multidrug resistance protei... 60 2e-08 1 18.6% 1:102 1:103 MNFVLIILSGVFDIFANLALQKSDGFRKIWWGILALVLVGSAFLLLAVVVdgMSLPIAYTLWGAIGILGSVAGAYYFFKQKLKPIGYVGIVLVVIAVALLQL---
237 UniRef50_C0R5F6 Small multidrug resistance ... 60 3e-08 1 39.8% 1:103 1:103 MCWLYLLLSSILEILWAVTLKFSNSFTKVVPSIATLVIMIISIYFLSLAACFLPIRVCYAVSSGICTIGITIIGATTFTENINLSQVLCIVLIVIGTIGLKLS--
238 UniRef50_D0S6P4 Quaternary ammonium compoun... 60 3e-08 1 22.9% 5:100 14:109 ----WLLFAIATDVLSTFYSARGNGLVNKTAQGIALILYMISFACAAIALKYMQAGILYVLWSGIGILATAFLAKIFLGQNIDVAGWVGIGFITVGLMII-----
239 UniRef50_A7GWZ5 Multidrug resistance protei... 60 3e-08 1 35.0% 1:103 2:108 MHFLALLGASACEVLGVYVLSMIEKSSKftLMALDICVLVLSLVLLRYAMQSLPMSVAYAIWTGLGAIGAVVVGIVINGEKFSLKKGVCLFLIIFSVIMLKIV--
240 UniRef50_UPI0000510168 hypothetical protein BlinB_... 57 2e-07 1 24.7% 3:83 5:84 --WVLLTGAVIAEVAGTLMLRAT--IENPLWILLVVISYALAFTLLGFTLrgLPIGVVYGTWAAFGVALVAVLGMVVFGDTLS----------------------
241 UniRef50_C8P7J0 Quaternary ammonium compoun... 57 2e-07 1 30.3% 39:104 16:81 --------------------------------------YGFCFFFLSLSLKGIKLNVAYATWGGAGIVLAALVSFFLFHEQTSGLQVFGIALIVVGGIIANLAG-
242 UniRef50_A1TK33 Small multidrug resistance ... 56 3e-07 1 36.4% 27:103 4:80 --------------------------SRRVPGIIGIFCILASFTALAQAVKGIDLSIAYALWGGTGIVLTSMAGWALFRQRLGRQAFAGILLIVAGISLLKLS--
243 UniRef50_B2HYG6 Quaternary ammonium compoun... 56 3e-07 1 22.9% 5:100 14:109 ----WLIFAIATDVLSTFYSAKGNGLVNKTAQGIALVLYIISFACAAIALKYMQAGILYVLWSGVGVLATAFLAKIFLGQNIDVAGWIGIGFITVGLMII-----
244 UniRef50_UPI0001B556AE small multidrug resistance ... 56 3e-07 1 30.8% 2:105 3:107 -AYLYLALAIAAEVTATVSLKLSEGFSKVTPSIFVVVGYGLAFFALSRVLkgLPIGVVYAVWAAAGVALVALVGVLFLKEPINLAIIAGLVLVIGGVVLIEVGSQ
245 UniRef50_B5GSQ3 Molecular chaperone n=1 Tax... 55 5e-07 1 55.4% 1:56 1:56 MAWVLLIIAGLLEVGWSIGMKFTEGFTKLWPSVFTGLGIVASMFLLAQAAKTLPIG-------------------------------------------------
246 UniRef50_A0K1G9 Small multidrug resistance ... 55 5e-07 1 42.3% 1:104 1:107 MSWLILIFSGALEAVWAAAlsQATGRRRVLPAAVFLVSVIASTGGLAIAMQSIPTGTAYAVWVGVGVVLTSAYAIVTKVERATAARLLLLAGIAASVVGLKVVA-
247 UniRef50_B2IXF4 Small multidrug resistance ... 53 3e-06 1 20.0% 1:100 11:120 LPWLIVTMSAFCNCLGNILIKQSRLASnsPWFIAGLIAYCIGLLLFAKALDKLPISIVVPTSQGIGFILVNFISYWLFKESLTFNQIIAVSLIFAGIVVI-----
248 UniRef50_A8Z6F2 Chaperonin n=5 Tax=Campylob... 53 3e-06 1 32.0% 2:101 5:105 -GFLWIFLGAVAECGWAYELKHA---SNLSEFLLTTLLVSISFVSFMKALKYLPVSISYAVFVGFGTVFIVIAEIvaSGIMPNFIRLFFIATLILGVLGLK----
249 UniRef50_D2QFV4 Small multidrug resistance ... 53 4e-06 1 33.7% 1:89 6:111 LSWLYLIGAAACEMAWMYALKYMrgLPTLLPWLAYVVFGIVNTVLLAIAMRTIPTTTAFAVWMALTLVFLKATDVLWLKISWSWAELFF----------------
250 UniRef50_Q4ZSY8 Probable 4-amino-4-deoxy-L-... 52 6e-06 1 23.2% 34:102 56:125 ---------------------------------ASITAYALSMLFWLLALRVLPLSRAYSLLSISYALVYTLAATlfFHETFTVSKTVGVSLIVAGVLTINL---
251 UniRef50_P55580 Uncharacterized protein y4n... 52 6e-06 1 26.7% 4:104 7:117 ---ILVFAAGLNSCIGNILLKWGRASLPppGFVGGVVFYGINVLLFAKALDSLEVSVAYPILAGSGFAMLIIASHYFFGEPFHLHKWIGVALVLVGIIFLARGG-
252 UniRef50_A1T0T0 Metal-dependent hydrolase i... 51 1e-05 1 20.8% 28:104 240:316 ---------------------------HLAVWLAGSLFIGTAYALVILAMQTLP--TAYVLstNIGILLAVVLSMLFFKDRVHlqKIVATLFITSGLLILGIFG-
253 UniRef50_Q1IWY4 SugE family protein n=1 Tax... 50 2e-05 1 26.8% 2:83 3:84 -AWIALFSAIACEVTGTLALKLLGLHTPWLALAVTGSLIVLSYLLLSLVFRRIPVAVAFAVWEAVGLAAVTLLSVWLLGDHLT----------------------
254 UniRef50_UPI0000382F84 COG2076: Membrane transport... 49 4e-05 1 33.3% 33:104 1:72 --------------------------------MIVALGYGTALWLMSTSMDMLPIGVVYAIWSGVGMVGAALGGALLYGEPLNATLLTGIGVIAVGVTILAIGQ-
255 UniRef50_Q3KCB8 Probable 4-amino-4-deoxy-L-... 48 1e-04 1 13.6% 20:100 32:110 -------------------LSWSRKWRSPWLWLALFAL-GSGLLVWLLVLQRLPVSVAYPMLS-LNFVIITLIARFVFKEPVDVQHWFGVLLVIGGVALL-----
256 UniRef50_A6VPT9 Small multidrug resistance ... 48 1e-04 1 22.2% 5:103 8:106 ----YIIIGASLECAWAYGLKHAADG---LEWAVTIFCIVASFWVFTKAFKYMGASIAYVLYTGLGTLFVVLLDMVTtgGAIDFVKLFFVVTLMSGVIVIKSA--
257 UniRef50_C9R2V3 DMT superfamily drug/metabo... 47 2e-04 1 24.1% 6:63 1:58 -----MAISICLEIVATNLLKVSDGFTKLVPTLGALAFYGCSFYFVSIIFRTLSVGLVINLFS------------------------------------------
258 UniRef50_C1TN93 Cation/cationic drug transp... 43 0.002 1 18.7% 30:104 49:123 -----------------------------PWAIVGVLLFGVSFIFMSAALSRVDLSVAYPLMSAMVYVLVLAVSVFWFGESMGLSKLLGIGAILFGVAALSVGG-
259 UniRef50_B4U9Y9 Small multidrug resistance ... 43 0.003 1 19.0% 17:100 18:101 ----------------NIAVKIGAIKSSKLFILAGLLGFGIQFLFYAFALKKINLSIAYPIMVGSGFVIISLFSYFYLKEHMNIYDFVGMVLIFVGVLLI-----
260 UniRef50_D0NVP2 Putative uncharacterized pr... 43 0.003 1 17.2% 7:105 124:232 ------VISAFMSIFGVNLQKYSHdtKRPIWWVGMFCVVGAsfLALGFAPQTLVASLG----GGSTILGNCLMSHFWLKQSLYLTDIVGVGFVSLGVVVLAAASE
261 UniRef50_A8F6Q2 Small multidrug resistance ... 43 0.004 1 20.9% 34:100 45:111 ---------------------------------LGLLFFGLSFVFYSLSLTKTKLSTAYPIMTGAGFIIVTVASILLFKENISSLKIVGILLIATGIWLV-----
262 UniRef50_A6VPU0 Small multidrug resistance ... 42 0.008 1 34.3% 1:102 1:106 MSFITLIIAGLFEVAGVSTLNVFStqRKTAFLLATIVLFAASLSSLSLAMQDILLSIAYAVWTGIGAAGAVAVGVWISKDKITLQKAAGLVLTITSAIALKV---
263 UniRef50_Q57479 QacC' protein n=3 Tax=Staph... 42 0.008 1 43.8% 1:32 1:32 MPYIYLIIAISTEVIGSAFLKSSEGFSKFIPS-------------------------------------------------------------------------
264 UniRef50_A1SS44 Small multidrug resistance ... 42 0.009 1 22.7% 1:97 1:110 MKWLILILGILSNASASVLIKVAMSSKEalPLVSGIALYGMAFILYALALTYLPLNIAHPILTSGSIALVSSASVLLFGENLSIINVAGIFFIIIGV--------
265 UniRef50_C3ZPL0 Putative uncharacterized pr... 42 0.009 1 20.0% 25:104 160:239 ------------------------GWKHGVHLIFLGCARFTSVICLFTAFQFIPPATAEAVWNASMPVFVVTLSCIFLQQIPTRVTILGSMWCVAGVVLLGYGS-
266 UniRef50_A9FVN6 Putative Conserved membrane... 41 0.011 1 17.2% 2:100 4:118 -GYLFLIIALVFNATANILMKLAsaLVTNYHLVLGLVLFASNILFYVLALKRINLSIAYPIMSSGGFLLISVFSVYFLHETLTGLQIGGIVLIAAGIALL-----
267 UniRef50_Q119S2 Putative uncharacterized pr... 41 0.012 1 20.3% 22:100 345:422 ---------------------KSKNFSLWWKVIGSAFFLFLSQVLIYISIGNIPTGIAMTIFF-IYPIITVLLSWGLFGDSPSVLRICAMVIIGLGGILV-----
268 UniRef50_B2B3K9 Predicted CDS Pa_6_6530 n=6... 41 0.012 1 17.0% 13:100 68:150 ------------EVAG-EGYGYLKNFYWWAGMILMILGEGLNfyAFTDAILVTPLG-------ALSVVITTILSAIFLKERLSMvkVACFLCIVGSVVIV-----
269 UniRef50_D0IVF5 Quaternary ammonium compoun... 41 0.015 1 18.4% 30:105 47:121 -----------------------------PWIYGAFVGYIGAFFTWMSLLKHAPIGPAFAA-SHLEIISVLAISYWLFNEPIGWPQIIGCLFIVAGIMCLAVSEK
270 UniRef50_C3Y6L2 Putative uncharacterized pr... 40 0.017 1 22.4% 38:104 87:153 -------------------------------------GAILSVLCLFMAYQFIPPATAEAVWNASMPVFVVTLSCIFLQQIPTRVTIIGSTCCVGGVVLLSYGS-
271 UniRef50_Q8YRE0 Alr3508 protein n=3 Tax=Cya... 40 0.018 1 21.0% 4:103 9:109 ---LLILTTVGLNTLAQTLLKLGAGQNPlfYLVGGICCYGLSTIFYVLVLGKLNLSIAYPLVIGLTIVLTTIAGAVVLREKVLVSQWIGIGLLLSGISAIALS--
272 UniRef50_A9WR83 SugE n=1 Tax=Renibacterium ... 40 0.021 1 47.4% 46:102 1:57 ---------------------------------------------MAWAMRTLPVGTAYAVWVGIGAVLTVAYAMITGTETVSLLKILLLLGIVSCVVGLKL---
273 UniRef50_C3XYB0 Putative uncharacterized pr... 40 0.022 1 9.0% 5:104 1196:1269 ----LVFLaaLCDMTGTSLM-----------YIGLTLTYASSFQMLRGAV----------------IIFTGLLSVAFLGRKLDWHHWCGIFFVLIGLILVGVSD-
274 UniRef50_B6FXS7 Putative uncharacterized pr... 40 0.022 1 14.1% 25:102 223:300 ------------------------NLTSCLVGIGVGIPNMFSSFFLIDALKTLEAAVVYPIFSAGGIVFIMFMSYLIFKERLSKKEKLAAALTIVSMAIVNI---
275 UniRef50_A7GQM9 Multidrug resistance protei... 40 0.027 1 28.6% 42:90 6:54 -----------------------------------------SFVFLSFTLKGIEMSIAYAIWSEMGIVTITIVDFFYLGENINLIKGLAI---------------
276 UniRef50_B6KM21 Putative uncharacterized pr... 40 0.029 1 20.5% 28:105 336:412 ---------------------------RPLWIVGMFLSVVINPFLTLVSYRFAAVSVV-AMFGGLHTLGSLVFARILLSEKLGWRDVVGGLLIVSGITEVVIFGH
277 UniRef50_C0Z9L4 Conserved hypothetical memb... 40 0.031 1 26.0% 18:94 39:113 -----------------LLLKFLHYFTNL-PIMVGLALYGLSAFIWIAALEKVQLSYAYPM-AALGYVLVAVLSFLIFNEPLSLTRIAGLAIIV-----------
278 UniRef50_C5BDR0 Membrane protein YfbJ n=2 T... 40 0.032 1 23.9% 30:100 46:117 -----------------------------WWLPGGILCYGLSMLCWLFALRDLPLNRAYPLLSLSYVLVCAlvSLPLFGERLNGGKLLGMGLIILGLLVI-----
279 UniRef50_C6RM55 Suppressor of gro n=3 Tax=G... 40 0.033 1 47.9% 20:67 1:48 -------------------MKLSADFIKLTPSIITLFFMVLSFGVLAYSMRTLSLGTAYTIWTDIGA--------------------------------------
280 UniRef50_B0SFC0 Cation transporter protein ... 39 0.036 1 23.4% 4:97 7:117 ---LFFCIAVFFNALANILIKTsdGFWNLVFTVfyFIAGLASFGLALLGykGLKLSLAYPVFTSSGFIIVLIASSVFFKERLNFTQWLGISFILVGV--------
281 UniRef50_B1FYR2 Small multidrug resistance ... 39 0.042 1 19.1% 12:100 33:120 -----------FEFTRANILPIAFRLATQPPIIGGLACYVISVVVWIVGLSRVDVSIAYPMLS-LGYIVNAFAAWYLFGEVLSVHKLVGIGVILVGVVIL-----
282 UniRef50_A8FRQ8 Probable 4-amino-4-deoxy-L-... 39 0.051 1 21.5% 22:100 55:134 ---------------------FSQALAPVMAVGAGLFCYALSMACWVMALKRLPLSIAYPLLS-LSYVLVYLGAVywLNEPLSWVKGTGIFLILLGLIFV-----
283 UniRef50_A3ERP6 Putative uncharacterized pr... 38 0.064 1 26.0% 33:105 26:97 --------------------------------LGGVFLQAIYYVLLLSLIQKAPVSLVVPM-TGFGYVLTAFLARIFLAEPVSPGRWAGIFLITVGVIFISRAGQ
284 UniRef50_D1P6P5 Integral membrane protein n... 38 0.069 1 17.1% 30:105 60:135 -----------------------------PWLVLSVLFHLGYIYFLSQAYNHGDLSQIYPISRGSAPLITALLSVVLFHEVLPILSFVGILLIISGVVAIAFAGR
285 UniRef50_D1HLK2 Whole genome shotgun sequen... 38 0.070 1 14.8% 41:101 600:664 ----------------------------------------CSFLLLQVLTEYILVSVTSAVTVTigVvvTILVAVFYFHDQFTWLKGVGLFTIMVGVSLFN----
286 UniRef50_Q3AD87 Membrane protein, putaive n... 38 0.079 1 21.1% 30:100 73:142 -----------------------------PYIIFGFLFYAVSSILWMFVLSKVDLSLAYPMLS-FGYVLVLVISKFFLHEAVSLQRWIGVFLICGGMILL-----
287 UniRef50_C2ECZ3 DMT superfamily drug/metabo... 38 0.083 1 18.4% 1:98 32:133 MTFGALIFAIVTTIFSFQHFLQYNSFKLWAVGIVSGLCWCLGQNNQFKAMKAIGVSKAVPISTGAQLVTTTIAGAIFFHEWTTTRQllALLFLVSGVV-------
consensus/100% .........................................................................................................
consensus/90% ................................hhhhh.hhhshhhh..shp.h.huhsYsha.uhuhhhh.hhuhhhhtp.hs..thh.h.hhh.shhhh.....
consensus/80% ...hhlhhuhh.Ehhhs..hp.stt.tt.h..hhhhhhhhhuhhhhshshptlsluhsYulasuhGhhhhshhuhhhhtp.hsh.thhhhhhlhhGlhhlp....
consensus/70% ..ahhLhhuhhhElhhs.hh+hspshpphh..lhshhhhshuhhhLuhuhcplsluhuYAlWsGlGhshsslhuhhhat-.hshhphhulshllsGllhlph...
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown